跳至主要内容
临床试验/NCT02500225
NCT02500225已完成4 期

Ulku Ozgul, Associate Professor, Inonu University, Department of Anesthesiology and Reanimation

Inonu University0 个研究点目标入组 25 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
25
主要终点
Motor (EMG) seizure duration

研究概览

简要总结

The purpose of the study was to investigate the effects of etomidate or sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles.

详细描述

Twenty-five patients will be a total of 150 ECT treatments in this prospective, double-blinded, crossover study. Each patient will receive either 0.2 mg/kg etomidate (Group 1) or 8% sevoflurane (Group 2) in 100% oxygen at 6 L/min fresh gas flow until loss of consciousness for their initial electroconvulsive therapy session. In subsequent sessions, patients will receive the alternative sevoflurane concentration and then alternated between doses until the sixth session. Muscle paralysis will achieve with 1 mg/kg succinylcholine. Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean arterial pressure (MAP) values, and recovery times will recorde.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Study include 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who schedule for ECT sessions under general anesthesia

排除标准

  • Pregnancy
  • Cerebrovascular disease
  • Unstable cardiovascular disease
  • Chronic obstructive pulmonary disease; and
  • Renal or hepatic failure

研究组 & 干预措施

Etomidate

Active Comparator

0.2 mg/kg etomidate during anesthesia induction

干预措施: Etomidate (Drug)

Etomidate

Active Comparator

0.2 mg/kg etomidate during anesthesia induction

干预措施: Sevoflurane (Drug)

8% sevoflurane

Active Comparator

Sevoflurane 8% concentration during anesthesia induction

干预措施: Etomidate (Drug)

8% sevoflurane

Active Comparator

Sevoflurane 8% concentration during anesthesia induction

干预措施: Sevoflurane (Drug)

结局指标

主要结局

Motor (EMG) seizure duration

时间窗: intraoperative

Motor seizure duration in electroconvulsive therapy

electroencephalography (EEG) seizure duration

时间窗: intraoperative

seizure duration in electroconvulsive therapy

次要结局

  • mean arterial pressure (MAP)((approximately 5 minutes for all measurements) prior to the seizure, after the anesthetic induction, and following the ECT session at 1 minute, 3 minutes, and 10 minutes)
  • heart rate (HR),((approximately 5 minutes for all measurements) prior to the seizure, after the anesthetic induction, and following the ECT session at 1 minute, 3 minutes, and 10 minutes)
  • recovery times((approximately 5 minutes for all measurements) prior to the seizure, after the anesthetic induction, and following the ECT session at 1 minute, 3 minutes, and 10 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ülkü Özgül

Associate Professor

Inonu University

相似试验